IN UKRAINE, THE PRODUCT IS KNOWN
UNDER IMMUNE COV BRAND
UNDER IMMUNE COV BRAND
Virlaza®️ is the latest development of Libi Pharm company
Virlaza® contributes to improving the symptoms associated with SARS-CoV2 (COVID-19), pneumonia, influenza, and other acute viral diseases, as follows:
reduced risk of ARDS development (the main cause of death from respiratory diseases) brought about by the body's response to coronavirus (COVID-19)
amelioration of respiratory disorders resulting from acute viral diseases
reduction of the inflammation that causes a cytokine storm
body temperature regulation
relief of side effects following vaccination
relief of hypoxic state associated with coronavirus and pneumonic fever
IN UKRAINE, THE PRODUCT IS KNOWN UNDER IMMUNE COV BRAND
It is a protected copyright product developed in 2020.
Besides, all the evidence now suggests that the use of Virlaza® can bring in a revolutionary change in the approach to therapy for a wide range of immunological disorders.
The terpenoids and terpenes comprising Virlaza®️ are known for their strong ability to protect cells from the most severe and adverse impacts.
Besides, all the evidence now suggests that the use of Virlaza® can bring in a revolutionary change in the approach to therapy for a wide range of immunological disorders.
The terpenoids and terpenes comprising Virlaza®️ are known for their strong ability to protect cells from the most severe and adverse impacts.
The remedy is completely organic and its composition contains unique plant extracts fortified by micronutrients.
The product does not contain GMO.
Ingredients: complex of terpenoids (monoterpenes, sesquiterpenes), flavonoids, phenolic compounds from extracts of: dianthus (Caryophylli flori), eucalyptus (Eucalypti aetheroleum), pine (Pini sylvestris), basil (Folium Ocimi Sancti), and salvia (Salviae officinalis foli).
Minerals: selenium, zinc.
Active ingredients: -eugenol, β-caryophyllen, -caryophyllen; 1.8-cineole; α-and β –pinene, γ-terpinene, α- terpinene, camphene, limonene, borneol, estragole (methyl chavicol), ocimene, methyleugenol; humulene, bornyl acetate, linalyl acetate, linalool, sclareol, α-terpineol; terpenoid compounds (monoterpene, sesquiterpene, iridoid), eugenol, cineole, ocimene, pinene, zinc, selenium.
The product does not contain GMO.
Ingredients: complex of terpenoids (monoterpenes, sesquiterpenes), flavonoids, phenolic compounds from extracts of: dianthus (Caryophylli flori), eucalyptus (Eucalypti aetheroleum), pine (Pini sylvestris), basil (Folium Ocimi Sancti), and salvia (Salviae officinalis foli).
Minerals: selenium, zinc.
Active ingredients: -eugenol, β-caryophyllen, -caryophyllen; 1.8-cineole; α-and β –pinene, γ-terpinene, α- terpinene, camphene, limonene, borneol, estragole (methyl chavicol), ocimene, methyleugenol; humulene, bornyl acetate, linalyl acetate, linalool, sclareol, α-terpineol; terpenoid compounds (monoterpene, sesquiterpene, iridoid), eugenol, cineole, ocimene, pinene, zinc, selenium.
• Patients suffering from COVID-19, influenza, and ARVI
• Patients suffering from pneumonia and ARDS (leading cause of death)
• Severe fever in inflammatory conditions
• Patients with oxidative stress
• Patients in the recovery/healing phase from COVID-19 and influenza
• Severe/marked side effects after COVID-19 vaccination
• Decreased immune response to pathogenic microorganisms
• Antimicrobial resistance
• MODS (multiple organ dysfunction syndrome) in patients with COVID-19, pneumonia, influenza
• Patients suffering from pneumonia and ARDS (leading cause of death)
• Severe fever in inflammatory conditions
• Patients with oxidative stress
• Patients in the recovery/healing phase from COVID-19 and influenza
• Severe/marked side effects after COVID-19 vaccination
• Decreased immune response to pathogenic microorganisms
• Antimicrobial resistance
• MODS (multiple organ dysfunction syndrome) in patients with COVID-19, pneumonia, influenza
Virlaza® effects - balancing of the body's immune system and preventing immunity overreaction (a cytokine storm), with simultaneous regulation of anti-inflammatory mechanisms, which may significantly improve recovery time.
Administration of Virlaza
1
As a preventive remedy, it is used the improvement of immunity and prevention of various diseases.
2
As an effective adjunct, the remedy is applied for faster recovery from diseases of various origin, including those caused by COVID-19.
3
It is used to reduce symptoms caused by side effects following COVID-19 vaccination.
4
In combination with prolonged antibiotic therapy.
For ARDS (Acute Respiratory Distress Syndrome)
Acute respiratory distress syndrome (ARDS) is one of the major problems in patients suffering from COVID-19 and pneumonia. It is also the leading cause of death from COVID-19.
Used as an aid to prescribed medicines, Virlaza® has shown to be potentially highly effective in conditions associated with ARDS.
Used as an aid to prescribed medicines, Virlaza® has shown to be potentially highly effective in conditions associated with ARDS.
The product may significantly alleviate the condition and reduce the symptoms associated with COVID-19, pneumonia, and influenza, shorten disease progression and prevent further complications.
Caution! The remedy is not monotherapy for treatment; it is vital to follow the recommendations of an attending physician, prescribed depending on the severity of a disease and a patient's condition.
Researches
Partners
Israel
Magdiel Pharmacy
Israel, Hod HaSharon, Wol. Magdiel 54
Shabit Pharmacy
Israel, Tel Aviv, 105 Derech HaShalom str.
Israel, Hod HaSharon, Wol. Magdiel 54
Shabit Pharmacy
Israel, Tel Aviv, 105 Derech HaShalom str.
Hungary
Biofora Herbal Ltd.
1061 Liszt Ferenc tér 10, Budapest. 1/11
1061 Liszt Ferenc tér 10, Budapest. 1/11
Proposals for cooperation are welcome!
By clicking on the button, you consent to the processing of personal
data and agree to the Privacy policy.
© 2021 | LibiPharm LLC
All Rights Reserved
Made with love for great people
All Rights Reserved
Made with love for great people
MENU
PRODUCTS
SUPPORT
